A comprehensive study examining 389 adults from the Alzheimer Biomarkers Consortium – Down Syndrome (ABC-DS) cohort has provided new insights into the relationship between cardiometabolic health and cognitive decline.
Researchers assessed the prevalence of metabolic syndrome and its components, then analysed their association with Alzheimer’s disease at baseline using logistic regression methods.
Surprisingly, the study found that the overall prevalence of metabolic syndrome was low in this group, despite a notably high rate of obesity.
Diabetes, high blood pressure, and high cholesterol—conditions linked to metabolic syndrome—appeared rarely in the group.
Overall, researchers found no significant link between metabolic syndrome and Alzheimer’s disease at baseline.
Obesity as a Key Risk Factor
Among the individual components analysed, obesity emerged as a significant factor.
Adults with obesity showed nearly three times higher odds of having Alzheimer’s disease compared to those without, with an odds ratio of 2.79 (P = 0.021).
Other cardiometabolic elements showed no statistically significant connection to Alzheimer’s in this cohort.
This finding suggests that in individuals with Down syndrome—who follow distinct neurodevelopmental and neurodegenerative patterns—traditional clustering of metabolic risk factors may not apply in the same way.
However, obesity independently increases dementia risk, even when full metabolic syndrome criteria aren’t met.
Clinical Relevance and Preventive Focus
For healthcare providers working with adults with Down syndrome, this study underscores the importance of regular obesity screening and active weight management discussions.
While metabolic syndrome itself may not be an immediate concern, the strong link between obesity and Alzheimer’s disease highlights the potential benefits of early lifestyle interventions.
Nutritional support, increased physical activity, and structured weight management programmes could all play a vital role in reducing long-term dementia risk.
Additionally, clinicians may need to continue monitoring cognition in obese individuals, especially when other risk factors are present.
These findings point toward the need for a tailored approach to metabolic health in adults with Down syndrome.
As researchers continue to explore how cardiometabolic patterns manifest differently in this population, clinicians may need to adapt screening thresholds and prevention strategies to better reflect unique risk profiles.
By focusing on obesity as a modifiable factor, caregivers and clinicians alike can take proactive steps to support healthier ageing and cognitive outcomes in individuals with Down syndrome.
Also Read: Fortis Doctor Warns Sweets Can Age You Faster; Shares Tips To Indulge Safely This Diwali
To read more such news, download Bharat Express news apps
